Long term safety and efficacy of open-label infliximab for SLE

被引：0
|
作者：
Aringer, M. [1 ]
Houssiau, F. [2 ,3 ]
Graninger, W. B. [4 ]
Feier, E. [5 ]
Steiner, G. [5 ]
Smolen, J. S. [5 ]
机构：
[1] Med Univ Vienna, Vienna, Austria
[2] Tech Univ Dresden, Univ Clin Ctr Carl Gustav Carus, Dresden, Germany
[3] Univ Catholique Louvain, Clin Univ St Luc, B-1200 Brussels, Belgium
[4] Med Univ Graz, Graz, Austria
[5] Med Univ Vienna, Vienna, Austria
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2007年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：455 / 455
页数：1
相关论文
共 50 条
  • [31] Long-term efficacy & safety of infliximab plus methotrexate for the treatment of polyarticular course juvenile rheumatoid arthritis: Findings from an open-label treatment extension.
    Lovell, D. J.
    Ruperto, N.
    Cuttica, R.
    Woo, P.
    Espada, G.
    Wouters, C.
    Silverman, E. D.
    Balogh, Z.
    Henrickson, M.
    Davidson, J.
    Foeldvari, I.
    Imundo, L.
    Simonini, G.
    Oppermann, J.
    Shen, Y. K.
    Visvanathan, S.
    Fasanmade, A.
    Mendelsohn, A.
    Giannini, E. H.
    Martini, A.
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S632 - S632
  • [32] Long-term safety and efficacy of belimumab in Japanese patients with SLE: A 7-year open-label continuation study (vol 33, pg 122, 2023)
    不详
    MODERN RHEUMATOLOGY, 2024,
  • [33] Safety and efficacy of eltrombopag for treatment of chronic immune thrombocytopenia: results of the long-term, open-label EXTEND study
    Saleh, Mansoor N.
    Bussel, James B.
    Cheng, Gregory
    Meyer, Oliver
    Bailey, Christine K.
    Arning, Michael
    Brainsky, Andres
    BLOOD, 2013, 121 (03) : 537 - 545
  • [34] Safety and Efficacy Of Long-Term Open-Label Romiplostim Dosing In Thrombocytopenic Pediatric Patients With Immune Thrombocytopenia (ITP)
    Tarantino, Michael D.
    Bussel, James B.
    Geddis, Amy
    Guerrera, Michael F.
    Ikeda, Alan K.
    Nie, Kun
    Eisen, Melissa
    BLOOD, 2013, 122 (21)
  • [35] Efficacy and safety of OM-8980 in patients with rheumatoid arthritis: An open-label, long-term, multicenter study
    Bandilla, K
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1999, 60 (12): : 638 - 649
  • [36] Treatment interruption did not impact efficacy or long-term safety of dupilumab: A phase 3 open-label trial
    Beck, L. A.
    Mette, D.
    Zhang, Q.
    Akinlade, B.
    Staudinger, H.
    Graham, N.
    Pirozzi, G.
    Ardeleanu, M.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2017, 137 (05) : S43 - S43
  • [37] Long-Term Efficacy and Safety of Etrasimod for Ulcerative Colitis: Results From the Open-Label Extension of the OASIS Study
    Chiorean, Michael
    Vermeire, Severine
    Panes, Julian
    Peyrin-Biroulet, Laurent
    Zhang, Jinkun
    Sands, Bruce E.
    Lazin, Krisztina
    Cabell, Chris H.
    Naik, Snehal U.
    Klassen, Preston
    Sandborn, William J.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S445 - S446
  • [38] MPOWERED Trial Open-Label Extension: Long-term Efficacy and Safety Data for Oral Octreotide Capsules in Acromegaly
    Fleseriu, Maria
    Molitch, Mark
    Dreval, Alexander
    Pokramovich, Yulia
    Bondar, Irina
    Poteshkin, Yury
    Macut, Djuro
    Obermayer-Pietsch, Barbara
    Gilgun-Sherki, Yossi
    Haviv, Asi
    Biermasz, Nienke
    Strasburger, Christian J.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2023, 108 (12): : 3214 - 3222
  • [39] A long-term, open-label study of the safety and efficacy of oral tazarotene in moderate to very severe plaque psoriasis
    Menter, A
    Lew-Kaya, D
    Beddingfield, F
    Walker, PS
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2004, 50 (03) : P2 - P2
  • [40] PULSAR Open-Label Extension: Long-Term Efficacy and Safety of Sotatercept for the Treatment of Pulmonary Arterial Hypertension (PAH)
    Humbert, M.
    Mclaughlin, V. V.
    Gibbs, S. R.
    Gomberg-Maitland, M.
    Hoeper, M.
    Preston, I. R.
    Souza, R.
    Waxman, A. B.
    Ghofrani, H. A.
    Subias, P. Escribano
    Feldman, J. P.
    Bohns Meyer, G.
    Montani, D.
    Olsson, K. M.
    Manimaran, S.
    Pena, J. de Oliveira
    Badesch, D. B.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
12345